Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Umo Capital Oy is a private investment company and multi-family office based in Helsinki, Finland, with a history dating back to 1949. The firm manages a diversified portfolio across multiple asset classes, including private equity, real estate, and public equities, with a focus on long-term capital preservation and growth. In the life sciences and healthcare sectors, Umo Capital operates as a strategic investor, participating in funding rounds for innovative biotechnology companies such as Faron Pharmaceuticals. The firm primarily targets investment opportunities within the Nordic region but maintains a globally diversified portfolio to capture broader market trends. Its investment philosophy emphasizes a dynamic allocation strategy that allows for proactive and flexible responses to market movements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UMO Capital.